Wockhardt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
1,995.00
-27.75 (-1.37%)
BSENSE

Jun 18

BSE+NSE Vol: 32.28 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 256229,
    "name": "Wockhardt",
    "stock_name": "Wockhardt",
    "full_name": "Wockhardt Ltd",
    "name_url": "stocks-analysis/wockhardt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,995.00",
    "chg": -27.75,
    "chgp": "-1.37%",
    "dir": -1,
    "prev_price": "2,022.75",
    "mcapval": "33,794.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532300,
    "symbol": "WOCKPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE049B01025",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "32.28 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/wockhardt-256229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zaynich antibiotic: How Wockhardt created India\\'s first FDA-approved drug | Pharma Industry",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-15 18:12:00",
        "description": "Zaynich antibiotic: How Wockhardt created India\\'s first FDA-approved drug | Pharma Industry  Business Standard..."
      },
      {
        "title": "Wockhardt Ltd eases for fifth straight session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-10 13:50:44",
        "description": "Wockhardt Ltd eases for fifth straight session  Business Standard..."
      },
      {
        "title": "Wockhardt Ltd leads losers in \\'A\\' group",
        "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcFE3QVV4VVJkaGZ5d3pUWDZSQ3VKSkNuZXNqNEhGYTlkVDlCQUo1Z0RCbk5aNnVHS0ExOS10WVNNSWJhVWF2cXpsbDB2OHdpeGkzVVMzVkdOVXY4a1NERG40QWtFQlNkM0NYa200ZzlHWXVGcFpYd3R1R3ZmUXZtYUdZekJCNDdNZzlDa0d2ZTJnQ21XQVdBdkdmQmY5SWpURDVmUDk2dm5Lem1OYVhQTTd3MG9CYjlWVGxV0gHAAUFVX3lxTE55WnFlX2VoTVJKX0U2ZVhLVDg1cUo4Zk9TdEJXS1hjQVRIRW5MSHlCYVRMaF91VGU3cW5xd2MxYTh3U3JzUUxicDUwNm9UUk9JR2tHLWZ4Q1B5OXB0ck84VE5fa1VPRWZXN1pxWHUzdldGQ0QxNjRIYkw4eXNYWWFORW0zTklYMzRKZFFNRVROdGR3Zy15NzZtRk50cmMzZDRGTWJvblRWaDNVa2RnUk5lOTJDNlJaeUFfbVh3aWROag?oc=5",
        "imagepath": "",
        "date": "2026-06-05 15:04:01",
        "description": "Wockhardt Ltd leads losers in \\'A\\' group  Business Standard..."
      },
      {
        "title": "Wockhardt Ltd leads losers in \\'A\\' group",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-05 15:04:01",
        "description": "Wockhardt Ltd leads losers in \\'A\\' group  Business Standard..."
      },
      {
        "title": "Wockhardt R&D Shift: Dr Khorakiwala On How Zaynich Success Transforms Biotech Capital Allocation",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-03 12:37:08",
        "description": "Wockhardt R&D Shift: Dr Khorakiwala On How Zaynich Success Transforms Biotech Capital Allocation  Business Today..."
      },
      {
        "title": "Wockhardt Shares Hit Record High As It Secures USFDA Approval For A Novel Antibiotic Zaynich",
        "link": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxNT2tXMjFHNGI5YkFGdlNSSHVQYTFsSzVUSTNIZjNpeFZ6NFZENHBiS05TN0xPTllWQWhybEFPZzhEV0lQOG5SaGtTdVVwYVA0Y25rQ3oxMDhxSlVvbEdVVlZSMkxnZlNGX3M4Z1RYQlJ1dWU2TlFTclg5S0pQTkFtTnZaYTJTSXFNRVRzMTI3R1Atc1dZRkJoMl8xd0x0NlM4RWgtWjBWTktNMUE5eDBfSkExbUdyREJTNFRkbjhYTkhRd21HNlBHcmp5R2YxNVNLQ0JBRExrUFhBWS1FN2U4ZUVRMWNrTXNXMzJrbWxn?oc=5",
        "imagepath": "",
        "date": "2026-06-02 15:02:26",
        "description": "Wockhardt Shares Hit Record High As It Secures USFDA Approval For A Novel Antibiotic Zaynich  Business Today..."
      },
      {
        "title": "Wockhardt corrects after blockbuster run on antibiotic approval",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-02 14:50:29",
        "description": "Wockhardt corrects after blockbuster run on antibiotic approval  Business Standard..."
      },
      {
        "title": "Wockhardt corrects after blockbuster run on antibiotic approval",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-02 14:50:29",
        "description": "Wockhardt corrects after blockbuster run on antibiotic approval  Business Standard..."
      },
      {
        "title": "Wockhardt shares tumble 9% amid profit booking after sharp rally on Zaynich approval",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-02 10:51:58",
        "description": "Wockhardt shares tumble 9% amid profit booking after sharp rally on Zaynich approval  BusinessLine..."
      }
    ],
    "total": 27,
    "sid": "256229",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/wockhardt-256229"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "11-Jun-2026",
      "details": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference no. Ref.no. WOCK/SEC/SE/2025-26/015 dated 1st June 2026 please find enclosed the transcript of the Investor Meeting held on Thursday 4th June 2026 for your information and records.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "04-Jun-2026",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "01-Jun-2026",
      "details": "Pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015 we wish to inform you that the Company will hold an Investor Meet on Thursday 4th June 2026 at 4:00 pm IST.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 16",
          "dt": "2016-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has announced <strong>3:10</strong> rights issue, ex-date: 08 Mar 22",
          "dt": "2022-03-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

11-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference no. Ref.no. WOCK/SEC/SE/2025-26/015 dated 1st June 2026 please find enclosed the transcript of the Investor Meeting held on Thursday 4th June 2026 for your information and records.

Announcement under Regulation 30 (LODR)-Investor Presentation

04-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

01-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015 we wish to inform you that the Company will hold an Investor Meet on Thursday 4th June 2026 at 4:00 pm IST.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22